Breast cancer characteristics at diagnosis and survival among Arab-American women compared to European- and African-American women

Henry Ford Hospital, Detroit, MI 48202, USA.
Breast Cancer Research and Treatment (Impact Factor: 3.94). 05/2008; 114(2):339-46. DOI: 10.1007/s10549-008-9999-z
Source: PubMed


Data from Arab world studies suggest that Arab women may experience a more aggressive breast cancer phenotype. To investigate this finding, we focused on one of the largest settlements of Arabs and Iraqi Christians (Chaldeans) in the US, metropolitan Detroit- a SEER reporting site since 1973.
We identified a cohort of primary breast cancer cases diagnosed 1973-2003. Using a validated name algorithm, women were identified as being of Arab/Chaldean descent if they had an Arab last or maiden name. We compared characteristics at diagnosis (age, grade, histology, SEER stage, and marker status) and overall survival between Arab-, European-, and African-Americans.
The cohort included 1,652 (2%) women of Arab descent, 13,855 (18%) African-American women, and 63,615 (80%) European-American women. There were statistically significant differences between the racial groups for all characteristics at diagnosis. Survival analyses overall and for each SEER stage showed that Arab-American women had the best survival, followed by European-American women. African-American women had the poorest overall survival and were 1.37 (95% confidence interval: 1.23-1.52) times more likely to be diagnosed with an aggressive tumor (adjusting for age, grade, marker status, and year of diagnosis).
Overall, Arab-American women have a distribution of breast cancer histology similar to European-American women. In contrast, the stage, age, and hormone receptor status at diagnosis among Arab-Americans was more similar to African-American women. However, Arab-American women have a better overall survival than even European-American women.

Download full-text


Available from: Christine C Johnson,
  • Source
    • "finding was also recently reported in non-IBC cases among Arab Americans (Alford et al. 2009). American Indian/Alaskan natives were found to have the shortest mean survival time, and efforts to reach these populations for early treatment of disease should become a priority. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Introduction Inflammatory breast cancer (IBC) is characterized by an apparent geographical distribution in incidence, being more common in North Africa than other parts of the world. Despite the rapid growth of immigrants to the United States from Arab nations, little is known about disease patterns among Arab Americans because a racial category is rarely considered for this group. The aim of this study was to advance our understanding of the burden of IBC in Arab ethnic populations by describing the proportion of IBC among different racial groups, including Arab Americans from the Detroit, New Jersey and California Surveillance, Epidemiology and End Results (SEER) registries. Methods We utilized a validated Arab surname algorithm to identify women of Arab descent from the SEER registries. Differences in the proportion of IBC out of all breast cancer and IBC characteristics by race and menopausal status were evaluated using chi-square tests for categorical variables, t-tests and ANOVA tests for continuous variables, and log-rank tests for survival data. We modeled the association between race and IBC among all women with breast cancer using hierarchical logistic regression models, adjusting for individual and census tract-level variables. Results Statistically significant differences in the proportion of IBC out of all breast cancers by race were evident. In a hierarchical model, adjusting for age, estrogen and progesterone receptor, human epidermal growth receptor 2, registry and census-tract level education, Arab-Americans (OR=1.5, 95% CI=1.2,1.9), Hispanics (OR=1.2, 95% CI=1.1,1.3), Non-Hispanic Blacks (OR=1.3, 95% CI=1.2, 1.4), and American Indians/Alaskans (OR=1.9, 95% CI=1.1, 3.4) had increased odds of IBC, while Asians (OR=0.6, 95% CI=0.6, 0.7) had decreased odds of IBC as compared to Non-Hispanic Whites. Conclusions IBC may be more common among certain minority groups, including Arab American women. Understanding the descriptive epidemiology of IBC by race may generate hypotheses about risk factors for this aggressive disease. Future research should focus on etiologic factors that may explain these differences.
    SpringerPlus 12/2013; 2(1):3. DOI:10.1186/2193-1801-2-3
    • "In the USA, research has been conducted to assess factors contributing to breast cancer disparities experienced by African-American women, who are often diagnosed with more advanced stages of breast cancer (Li, Malone, and Daling 2003; Smith- Bindman et al. 2006; Hahn et al. 2007; Barrett et al. 2008; Morris and Mitchell 2008; Hensley Alford et al. 2009). Underlying factors include limited access to health care (Ghafoor et al. 2003), diagnostic and treatment delays (Gorin et al. 2006), low use of repeat screening and inadequate follow-up for abnormal exams (Jones, Patterson, and Calvocoressi 2003), in addition to low uptake of mammography (Smith, Cokkinides, and Eyre 2004) and greater likelihood of more aggressive disease (Morris and Mitchell 2008). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background. There are no published data on barriers to breast cancer screening in Barbadian women, who experience a lower incidence yet similar mortality rate to African American women. Attitudes, beliefs and knowledge about breast cancer, including screening procedures, have been identified as barriers to screening among African American and Caribbean women in the USA. Objective. This qualitative study examined the beliefs about mammography among Barbadian women, in order to identify barriers to breast cancer screening for this population. Method. One hundred and ten participants were recruited from a primary healthcare facility and breast cancer-screening program run by a local charity. Interviews were conducted through 12 focus groups stratified by previous mammogram status (yes vs. No) and age-group (40-49, 50-59, 60-69 and 70+ years). Qualitative analyses were carried out using QSR NVivo 8. Results. For all age groups, lack of/erroneous health information, fear and cost were identified as the principal barriers to breast cancer screening. However, specific beliefs/fears varied by age group (e.g. younger women feared losing a romantic relationship after diagnosis, while older women believed that the mammography machine causes breast cancer). The taboo societal perception of breast cancer was also identified as a major barrier to screening. Conclusions. Three main categories of breast cancer screening barriers among Barbadian women were identified, although within categories, differences were observed between age-groups. If screening is to be increased in this population, health messages should be tailored for each category and age group, providing accurate information to dispel myths and provide support.
    139st APHA Annual Meeting and Exposition 2011; 11/2011
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Prophylactic cranial irradiation has been used in patients with small cell lung cancer to reduce the incidence of brain metastasis after primary therapy. The purpose of this study was to evaluate the effects of prophylactic cranial irradiation (PCI) on overall survival and cause-specific survival. A total of 7995 patients with limited stage small cell lung cancer diagnosed between 1988 and 1997 were retrospectively identified from centers participating in the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program. Of them, 670 were identified as having received PCI as a component of their first course of therapy. Overall survival and cause-specific survival were estimated by the Kaplan-Meier method, comparing patients treated with or without prophylactic whole-brain radiotherapy. The Cox proportional hazards model was used in the multivariate analysis to evaluate potential prognostic factors. The median follow-up time was 13 months (range, 1 month to 180 months). Overall survival at 2 years, 5 years, and 10 years was 23%, 11%, and 6%, respectively, in patients who did not receive PCI. In patients who received PCI, the 2-year, 5-year, and 10-year overall survival rates were 42%, 19%, and 9%, respectively (P =or <.001). The cause-specific survival rate at 2 years, 5 years, and 10 years was 28%, 15%, 11%, respectively, in patients who did not receive PCI and 45%, 24%, 17%, respectively, in patients who did receive PCI (P =or <.001). On multivariate analysis of cause-specific and overall survival, age at diagnosis, sex, grade, extent of primary disease, size of disease, extent of lymph node involvement, and PCI were found to be significant (P = or<.001). The hazards ratios for disease-specific and all cause mortality were 1.13 and 1.11, respectively, for those not receiving PCI. Significantly improved overall and cause-specific survival was observed in patients treated with prophylactic cranial irradiation on unadjusted and adjusted analyses. This study concurs with the previously published European experience. Prophylactic cranial irradiation should be considered for patients with limited stage small cell lung cancer.
    Cancer 02/2009; 115(4):842-50. DOI:10.1002/cncr.24105 · 4.89 Impact Factor
Show more